The construction of Moderna’s Innovation and Technology Centre (MITC) at Harwell Campus has been completed. This state-of-the-art facility will serve as Moderna’s base for research, development, and manufacturing. The project is part of a 10-year partnership with the UK Government, managed by the UK Health Security Agency (UKHSA).
The centre aims to produce British-made COVID-19 vaccines and explore the potential of Moderna’s mRNA platform to transform UK healthcare.













